Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Federico
Outcome and Treatment of Relapsing Early Pet Negative Patients Included in the Eortc/Lysa/Fil H10 Trial on Stages I/Ii Hodgkin Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
The T Cell Project 2.0: The More We Register, the More We Learn
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Pod24 and Cr30 Are Promising Surrogate Endpoints for Assessing the Outcome of Patients With Advanced Stage Follicular Lymphoma Enrolled in the Foll05 Trial by Fil.
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Response Oriented Maintenance Therapy in Advanced Follicular Lymphoma. Results of the Interim Analysis of the Foll12 Trial Conducted by the Fondazione Italiana Linfomi.
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Impact of Pet Imaging and Histologic Transformation on the Prognosis of Early Disease Progression in Follicular Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Autologous Stem Cell Transplantation as Part of First-Line Therapy in Patients With Peripheral T-Cell Lymphoma: A Multicenter Geltamo/Fil Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Improved Survival Outcomes for Patients With Extra-Nodal Nk/T Lymphoma: Data From 140 Patients Prospectively Registered in the International T-Cell Project
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Novel Molecular Markers for Minimal Residual Disease (Mrd) Monitoring in Mantle Cell and Follicular Lymphoma: The Targeted Locus Amplification (Tla) NGS Strategy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Anaplastic Large Cell Lymphoma, Alk-Negative: Analysis of 235 Cases Collected by the T-Cell Project
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Preliminary Results of a Quality Control Study on Involved Node Radiotherapy in the Eortc/Lysa/Fil H10 Trial on Stages I/Ii Hodgkin Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
1
2
›